(NEW YORK)Shares of United Therapeutics Corp. plunged Monday after the company said a new formulation of its hypertension drug Remodulin failed to meet its goal in a late-stage study.READ MORE
In early trading Monday, United Therapeutics Corp. (Nasdaq:UTHR) shares fell more than 30 percent on Monday after it said one of its treatments in the FREEDOM-C RIAL did not meet i...READ MORE
(SILVER SPRING, Md.)Biotechnology company United Therapeutics Corp. said Monday an oral sustained-release version of its hypertension drug Remodulin failed a late-stage study.READ MORE
(SILVER SPRING, Md.)Biotechnology company United Therapeutics Corp. said Monday it is licensing rights to sell Eli Lilly & Co.'s erectile dysfunction drug Cialis as a hypertension treatment in the U.S...READ MORE
(NEW YORK)Standard & Poor's says it will remove Fannie Mae and Freddie Mac from the S&P 500 after close of trading Wednesday, following a dramatic drop in the mortgage giants' stock prices.READ MORE
(NEW YORK)A buyout bull's-eye will likely remain on biotechnology companies over the next few years as major pharmaceutical companies continue taking advantage of a weak dollar and a surplus...READ MORE